Cerulean Pharma (CERU) Tops Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cerulean Reports Second Quarter 2015 Corporate Highlights and Financial Results
August 6, 2015 4:09 PM EDTStrengthened Balance Sheet with Underwritten Public Offering of Common Stock
Conference Call Today at 4:30 pm
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cerulean Pharma Inc. (Nasdaq: CERU) today provided an update on corporate activities during the quarter ended June 30, 2015.
Cerulean strengthened its balance sheet and team during the second quarter, commented... More
